OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 126 filers reported holding OCULAR THERAPEUTIX INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,773 | -69.8% | 17,125 | -50.4% | 0.00% | – |
| Q2 2023 | $178,087 | +90.0% | 34,513 | +94.0% | 0.00% | – |
| Q1 2023 | $93,748 | +1610.7% | 17,789 | +812.3% | 0.00% | – |
| Q4 2022 | $5,480 | -79.7% | 1,950 | -70.1% | 0.00% | – |
| Q3 2022 | $27,000 | -6.9% | 6,512 | -8.5% | 0.00% | – |
| Q2 2022 | $29,000 | -63.8% | 7,117 | -56.1% | 0.00% | – |
| Q1 2022 | $80,000 | -72.6% | 16,220 | -61.4% | 0.00% | – |
| Q4 2021 | $292,000 | -48.3% | 42,036 | -25.6% | 0.00% | – |
| Q3 2021 | $565,000 | -44.9% | 56,486 | -21.9% | 0.00% | – |
| Q2 2021 | $1,025,000 | -89.4% | 72,311 | -87.7% | 0.00% | -100.0% |
| Q1 2021 | $9,677,000 | +54.5% | 589,732 | +94.9% | 0.00% | 0.0% |
| Q4 2020 | $6,264,000 | +393.6% | 302,643 | +81.4% | 0.00% | – |
| Q3 2020 | $1,269,000 | +123.4% | 166,811 | +144.6% | 0.00% | – |
| Q2 2020 | $568,000 | +116.8% | 68,199 | +28.9% | 0.00% | – |
| Q1 2020 | $262,000 | +21.3% | 52,928 | -3.4% | 0.00% | – |
| Q4 2019 | $216,000 | +28.6% | 54,786 | -0.5% | 0.00% | – |
| Q3 2019 | $168,000 | +23.5% | 55,079 | +78.7% | 0.00% | – |
| Q2 2019 | $136,000 | +1.5% | 30,825 | -8.7% | 0.00% | – |
| Q1 2019 | $134,000 | 0.0% | 33,761 | -0.1% | 0.00% | – |
| Q4 2018 | $134,000 | -56.8% | 33,807 | -25.0% | 0.00% | – |
| Q3 2018 | $310,000 | +39.6% | 45,046 | +37.0% | 0.00% | – |
| Q2 2018 | $222,000 | +1.8% | 32,876 | -1.8% | 0.00% | – |
| Q1 2018 | $218,000 | -26.4% | 33,483 | -49.7% | 0.00% | – |
| Q4 2017 | $296,000 | -36.1% | 66,599 | -11.2% | 0.00% | – |
| Q3 2017 | $463,000 | -34.0% | 75,001 | -0.9% | 0.00% | – |
| Q2 2017 | $701,000 | -13.1% | 75,650 | -13.1% | 0.00% | – |
| Q1 2017 | $807,000 | +38.7% | 87,046 | +25.1% | 0.00% | – |
| Q4 2016 | $582,000 | +118.8% | 69,601 | +79.9% | 0.00% | – |
| Q3 2016 | $266,000 | +41.5% | 38,680 | +2.0% | 0.00% | – |
| Q2 2016 | $188,000 | -56.2% | 37,928 | -14.5% | 0.00% | – |
| Q1 2016 | $429,000 | +108.3% | 44,353 | +101.7% | 0.00% | – |
| Q4 2015 | $206,000 | -31.8% | 21,993 | +2.5% | 0.00% | – |
| Q3 2015 | $302,000 | -11.2% | 21,454 | +32.5% | 0.00% | – |
| Q2 2015 | $340,000 | -31.2% | 16,191 | +37.4% | 0.00% | – |
| Q1 2015 | $494,000 | +8133.3% | 11,784 | +4313.5% | 0.00% | – |
| Q4 2014 | $6,000 | – | 267 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |